ABSTRACT
Introduction
Seizures are the most common clinical manifestation of neurological dysfunction in newborns. They usually reflect a serious underlying condition such as hypoxic-ischaemic encephalopathy, stroke, haemorrhage, acute infection, hypoglycaemia or other metabolic disorder or brain malformations. (1) The estimated incidence of neonatal seizures is 2 -3 per 1000 term newborns and 10 -15 per 1000 preterm newborns. ( 2) The accumulating experimental data from animal studies suggest that seizures may lead to persistent neurological sequel by interfering with the proper construction of cortical neuronal networks. (3, 4) Although mortality rates have been reduced, the morbidity rate remains high, with epilepsy being a frequent sequel. In addition, the development of epilepsy is strongly associated with other permanent neurologic disorders such as intellectual disability and cerebral palsy. (5-7) The occurrence of epilepsy after neonatal seizures varies in frequency, as reported in previous studies, from 3.5% to 56%. (2, 8, 9) Clinical studies suggest that the aetiology of neonatal seizures is the most important factor influencing the outcome.
(9) Other prognostic factors reported in the literature are interictal electroencephalographic features and early onset of seizures. (10, 11) Establishing the risk factors that predict the development of epilepsy would allow clinicians to identify children at high risk and to plan longterm follow-up and health assistance. The aim of this study was to analyse clinical, laboratory, neurophysiological and neuroimaging risk factors for epilepsy in a group of children with neonatal seizures.
Patients and Methods
The retrospective study included newborns admitted to the Neonatal 
Results
During the study period, 176 children, 72 (40.9%) female and 104 male (59.1%), with neonatal seizures were identified. Their birth weight was from 620 grams to 4500 grams, mean 2820 grams; 
Discussion
Many studies have demonstrated that neonatal seizures are a significant cause of death and adverse neurodevelopmental outcomes, such as cerebral palsy, developmental delay and epilepsy. (11) The follow up period in our cohort was from one to almost ten years and we found that 18% of children who experienced neonatal seizures developed epilepsy. The result is similar to previous contemporary cohorts that used broad clinical and/or electrographic definitions for neonatal seizures. On the contrary, some studies that included only children with seizures confirmed by EEG found a lower incidence rate, which reflects problems in the definition of neonatal seizures as the same epileptic discharges may not be detectable by surface EEG studies. (12, (14) (15) (16) Neonatal seizures usually reflect underlying aetiology. The majority of seizures in our population were symptomatic, and different factors from a broad spectrum of aetiologies were identified. Hypoxic-ischaemic encephalopathy (HIE) was identified in the majority of infants in our group. It has also been the leading cause for neonatal seizures in previous studies, though the incidence varied, probably as a result of inconsistent diagnostic criteria used. (9) However, HIE was not associated with an adverse outcome and this was also demonstrated in previous reports, where neonatal seizures and the severity of hypoxic-ischaemic encephalopathy were independently associated with eventual outcome. (17, 18) Pathologic CTG, reflecting a hypoxic ischaemic event, also proved to be independently associated with epilepsy in our study. Among other aetiological factors for neonatal seizures, metabolic disorders -inborn error of metabolism and hypoglycaemia -were significantly associated with epilepsy. There are several putative mechanisms for hypoglycaemiainduced cellular injury, including excitatory neurotoxins active N-methyld-aspartate receptors, increased mitochondrial free radical generation and initiation of apoptosis and altered cerebral energetic characteristics. (19) Authors who have studied outcomes associated with neonatal hypoglycaemia have reported visual impairments and epilepsy, with the parietal and occipital lobes being affected most severely. (19) Although the exact prognostic value of the presence of specific seizure types remains a challenge for the clinician, a number of studies converge in reporting that patients with other than focal seizures have a worse outcome compared to those with focal seizures. (20, 21) Our results support this observation as myoclonic seizures were statistically significant for developing epilepsy. We also proved the correlation between the myoclonic type of seizures and an underlying metabolic aetiology, so in our future work, we should further elucidate a possible classification of epileptic syndrome (Early myoclonic epileptic encephalopathy). (22) The severity and pattern of neuroimaging studies are known risk factors for neonatal seizures and subsequent epilepsy, and we also showed a clear relationship between the results of neuroimaging studies and epilepsy. This relationship is the result of preexisting brain abnormalities, which lead to seizures but there is controversy from animal studies regarding whether neural injury can cause changes in excitability, sufficiently to result in unprovoked seizures beyond the neonatal period. (23) Neurologic assessment across the studies is highly predictive for long-term outcome. (9) The Amiel-Tison neurologic assessment proved to be useful in recognizing children who have normal development despite different perinatal risk factors, and in identifying those children who have adverse neurological outcomes and delayed developmental performance. (24, 25) Our study also proved the value of this method of assessment for identifying children with epilepsy. The high predictive value of abnormal EEG background activity for outcome in neonates with seizures is already well known and was also proved in our study. (9, 10, 26) Some other studies showed that sequential EEG recordings have better predictive value; they demonstrated that sequential EEG background activity was strongly correla- 
Conclusion
Epilepsy is an outcome following neonatal seizures in the setting of different neurologic dysfunctions in the neonatal period. Our data provide further information for clinicians and parents planning long-term care for children with neonatal seizures. Children with metabolic disorders, those who needed resuscitation after birth and had a pathologic CTG, those with myoclonic or more than one type of seizures, and those in whom seizures persisted after the first month of life and needed treatment after the neonatal period, are at a high risk for epilepsy. In the future, new neuroprotective and antiepileptic agents should be studied in neonates with the presented risk factors.
